Using virtual reality meditation to relieve cancer pain
Official title: Study With Cancer Patients at the CECON Foundation's Pain Therapy and Palliative Care Service: Meditation With Immersive Virtual Reality for Pain Relief
Run by Fundação Centro de Controle de Oncologia Do Estado Do Amazonas · NCT06328751 · Data updated 2026-11-12
This study is testing whether virtual reality meditation can help cancer patients manage their chronic pain and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 129 (estimated) |
| Sponsor | Fundação Centro de Controle de Oncologia Do Estado Do Amazonas Research network |
| Locations | 1 site (Manaus, Amazonas) |
| Status | Recruiting |
| Started | November 7, 2024 |
| Main results expected | January 2026 |
| Study ends | January 2027 |
| Registry record updated | March 12, 2025 |
| Trial ID | NCT06328751 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are cancer patients aged 18 to 75 who are experiencing chronic pain and are receiving care at the Pain Therapy and Palliative Care Service.
✕Probably not a fit
Patients with serious psychiatric illnesses or those unable to understand or communicate effectively may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores the use of immersive virtual reality to facilitate meditation practices among cancer patients experiencing chronic pain. It involves a randomized controlled trial with 129 participants divided into three groups: an experimental group using VR meditation, an active control group using a mobile phone for meditation, and a passive control group. Participants will undergo assessments of their quality of life, psychological well-being, and pain levels before and after the intervention. The goal is to determine the effectiveness of virtual reality meditation in improving pain management and overall quality of life for cancer patients.
Why it matters
Potential benefit: If successful, this approach could provide a novel, non-invasive method for managing cancer pain and enhancing the quality of life for patients.
How similar studies have gone: While the use of virtual reality in pain management is gaining interest, this specific approach combining VR with meditation is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be followed up at the Pain Therapy and Palliative Care Service (STDCP) to control symptoms resulting from any type of cancer at any stage; * Have a diagnosis of chronic pain, recorded in the medical records. * Be between 18 and 75 years old on the date of the first collection; * Be able to understand Portuguese (read and write); * Have normal vision and hearing; * Have a cell phone with an Android system; * Be able to make head movements and have sufficient motor control to make body movements; * Agree to take part in the study and sign the Informed Consent Form (ICF). Exclusion Criteria: * Indigenous patients (due to cultural and linguistic peculiarities and special legislation); * Patients with records of serious psychiatric illnesses (DSM-5 - Diagnostic and Statistical Manual of Mental Disorders - schizophrenia, schizotypal disorders, delusional disorders, borderline and dementias); * Impairment of the ability to understand or communicate based on the researcher's assessment; * Report of discomfort with the use of Immersive Virtual Reality; * Progression of the disease with limitation in maintaining the proposed regular outpatient visits; * Patients with brain tumors, brain metastases or a previous history of seizures.
Where it's running
-
Fundação Centro de Controle de Oncologia do Estado do Amazonas - FCECON
Manaus, Amazonas, Brazil Recruiting
Study contacts
- Principal investigator: Emily S Montarroyos — Fundação Centro de Controle de Oncologia do Estado do Amazonas (FCECON)
- Study coordinator: Emily S Montarroyos
- Email: emilymontarroyos@hotmail.com
- Phone: +55 (92) 988024440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Triple-target radiosurgery for cancer pain using pituitary and thalamic neuromodulation
This study tests whether focused brain radiosurgery to the pituitary and specific thalamic regions can reduce pain in adults with cancer that’s not controlled by opioids or other treatments.
-
Hydromorphone plus electroacupuncture and ear acupressure for refractory cancer pain
This trial tests whether adding electroacupuncture and ear acupressure to hydromorphone extended-release tablets helps relieve refractory cancer pain.
-
Tibetree topical herbal plasters for people using opioids for cancer pain
This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.
-
Transdiscal versus paravertebral splanchnic nerve neurolysis for upper abdominal cancer pain
This will test whether the transdiscal or the paravertebral splanchnic nerve neurolysis gives better pain relief for people with severe upper abdominal cancer pain that hasn't responded to medicines.
-
MRI-guided focused ultrasound mesencephalotomy for opioid-resistant head, neck, and brachial cancer pain
This study will try MRI-guided focused ultrasound to make a tiny, precise lesion in the midbrain to relieve severe, opioid-resistant head, neck, or brachial cancer pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.